Please ensure Javascript is enabled for purposes of website accessibility

Why Globus Medical Stock Soared Today

By Keith Speights - Aug 6, 2020 at 3:51PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The medical device maker reported second-quarter results that were much better than expected.

What happened

Shares of Globus Medical (GMED 0.23%) were soaring 13.9% higher as of 3:21 p.m. EDT on Thursday. The big jump came after the medical device maker reported its second-quarter results before the market opened.

So what

Globus Medical announced revenue in the second quarter of $148.9 million, down 23.4% year over year. It posted a net loss in Q2 of $20.8 million, or $0.21 per share, based on generally accepted accounting principles (GAAP). That reflected a sharp decline from GAAP earnings of $38.2 million, or $0.38 per share, in the prior-year period. However, the company reported adjusted earnings of $0.07 per share.

Surgical robot arms

Image source: Getty Images.

So why did the healthcare stock surge with year-over-year declines on both the top and bottom lines? Globus blew past expectations. It topped the consensus Wall Street estimate for revenue in Q2 by more than 49%. The company's adjusted earnings were nearly 164% better than expected.

Lower sales and earnings in the second quarter were a foregone conclusion for Globus Medical with the COVID-19 pandemic causing patients to delay elective procedures. However, in a statement, CEO Dave Demski said the 23% revenue decline as "an exceptional result when compared to our peers within the industry."

Now what

Globus Medical should return to growth soon. Demski said that the company's manufacturing has continued at a record pace "in anticipation of the bounce back we are already starting to see." He noted that U.S. spine procedures are rebounding after hitting bottom in mid-April. Demski added that "Globus is poised for robust growth if the recent trends continue."

Keith Speights has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Globus Medical. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Globus Medical, Inc. Stock Quote
Globus Medical, Inc.
GMED
$65.31 (0.23%) $0.15

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
390%
 
S&P 500 Returns
125%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 08/11/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.